
Mycobacterium tuberculosis [44]


Samuel Alvarez Arguesdas
Integrated Mycobacterial Pathogenomics
Samuel Álvarez-Arguedas is doing his PhD in Biochemistry and Molecular Biology at the University of Zaragoza, Spain, under the supervision of Prof. Carlos Martín, focusing on the study and characterization of the new tuberculosis vaccine, […]

TBVAC 2020
Roland Brosch

SUPERCPLX
Marco Bellinzoni

Alexandre Giraud–Gatineau
Biology of Spirochetes
Alexandre is a PhD student from the University Paris VII. He is graduated for a Master degree in 2016 from the University Pierre et Marie Curie, Paris. He studied the efficacy of TB drugs encapsulated with […]

Matthias Groschel
Integrated Mycobacterial Pathogenomics
Tuberculosis (TB) affects mostly young people in their most productive years and the long treatment with its many side effects is a challenge for patients. A vaccine that protects better from developing TB or […]

(FR) Tuberculosis Research Laboratory – Institut Pasteur Korea

Inhibitors of TMPK from Mycobacterium tuberculosis
Hélène Munier-Lehmann • Sylvie Pochet

Identifying host genetic factors that affect the interplay between M. tuberculosis and human cells
Ludovic Tailleux

Vladimir Pelicic

Christophe Guilhot

Antibiotic resistances and drug screening
Brigitte Gicquel

Nanotherapeutics for Antibiotic Resistant Emerging Bacterial pathogens
Brigitte Gicquel

Inosine-5′-monophosphate dehydrogenase
Hélène Munier-Lehmann

Nucleoside monophosphate kinases (NMPKs)
Hélène Munier-Lehmann
